Christopher Staten - 30 Jul 2021 Form 3 Insider Report for AERIE PHARMACEUTICALS INC

Role: Interim CFO
Signature: /s/ John LaRocca, Attorney-in-Fact for Christopher Staten
Issuer symbol: N/A
Transactions as of: 30 Jul 2021
Net transactions value: $0
Form type: 3
Filing time: 05 Aug 2021, 17:43:06 UTC
Next filing: 17 Aug 2021
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
holding	AERI	Common Stock						22,587	30 Jul 2021	Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
holding	AERI	Stock Option (right to buy)							30 Jul 2021	Common Stock	59,500	$24.70	Direct	F1
holding	AERI	Stock Option (right to buy)							30 Jul 2021	Common Stock	14,650	$43.90	Direct	F1
holding	AERI	Stock Option (right to buy)							30 Jul 2021	Common Stock	13,835	$56.25	Direct	F2
holding	AERI	Stock Option (right to buy)							30 Jul 2021	Common Stock	12,516	$46.86	Direct	F3
holding	AERI	Stock Option (right to buy)							30 Jul 2021	Common Stock	12,516	$23.97	Direct	F4
holding	AERI	Stock Option (right to buy)							30 Jul 2021	Common Stock	12,516	$12.71	Direct	F5
holding	AERI	Stock Option (right to buy)							30 Jul 2021	Common Stock	12,516	$16.22	Direct	F6

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	These options are fully vested as of the date hereof.
F2	These options have vested, or are scheduled to vest, subject to the reporting person's continued employment with the issuer through the applicable vesting date, in substantially equal installments on each of the first 48 monthly anniversaries of January 30, 2018.
F3	These options have vested, or are scheduled to vest, subject to the reporting person's continued employment with the issuer through the applicable vesting date, in substantially equal installments on each of the first 48 monthly anniversaries of January 30, 2019.
F4	These options have vested, or are scheduled to vest, subject to the reporting person's continued employment with the issuer through the applicable vesting date, in substantially equal installments on each of the first 48 monthly anniversaries of August 14, 2019.
F5	These options have vested, or are scheduled to vest, subject to the reporting person's continued employment with the issuer through the applicable vesting date, in substantially equal installments on each of the first 48 monthly anniversaries of August 14, 2020.
F6	These options have vested, or are scheduled to vest, subject to the reporting person's continued employment with the issuer through the applicable vesting date, in substantially equal installments on each of the first 48 monthly anniversaries of July 1, 2021.